Abstract
Cancer epigenetics is hot. At the annual meeting of the American Association for Cancer Research in April, once-obscure principal investigators were feted by gaggles of admirers and many poster presenters mobbed by the curious. “It’s one of the hottest areas of basic biology,” said Paul Workman, Ph.D., director of cancer therapeutics at Cancer Research U.K. in Sutton, England.

This publication has 0 references indexed in Scilit: